CMPX

CMPX Stock-Based Compensation

$12.96MTTM · USD

Period ending:

CMPX FY Stock-Based CompUSD
CMPX FY Stock-Based Comp2019-03-31: $656.00K2020-03-31: $915.00K2020-12-31: $4.02M2021-12-31: $4.03M2022-12-31: $5.33M2023-12-31: $6.12M2024-12-31: $8.56M2025-12-31: $8.37M$8.56M$0.00
2019-03-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

CMPX stock-based compensation history

Non-cash compensation expense paid in equity. The available annual fiscal periods series contains 8 observations from Mar 31, 2019 to Dec 31, 2025.

Compass Therapeutics Stock-Based Compensation — Annual fiscal periods (USD)
Period endingStock-Based Compensation (USD)
8,368,000
8,560,000
6,120,000
5,330,000
4,029,000
4,016,000
915,000
656,000

Compare stock-based compensation

All CMPX financial metrics · CMPX stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.